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Captopril improves recovery of adenosine triphosphate during 
reperfusion of the ischemic isolated rat heart; a 31-phosphorus- 
nuclear magnetic resonance study 
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and C. R. H. Wildevuur 1)
x) Department ofCardiopulmonary Surgery, Research Division 
2) Department ofPharmacology/Clinical Pharmacology 
3) Department ofPhysical Chemistry, The Netherlands 
Summary: The effect of captopril on energy-rich phosphates and pH during normothermic ischemic 
arrest, hypothermic cardioplegic arrest and subsequent reperfusion was investigated inthe isolated rat 
heart using 31P-nuclear magnetic resonance. The hearts remained in the probe during all perfusion 
procedures and captopril (80 ml. 1 -j) treatment was started irectly after cannulation. 
After normothermic ischemic arrest (15 min), the ATP content of captopril-treated hearts was not 
significantly different from that of untreated hearts (53 + 9 % and 52 + 8 %, respectively). Accumula- 
tion of inorganic phosphate at the end of ischemia was significantly ess in treated hearts, suggesting a 
higher end-ischemic nucleotide ontent in treated hearts. 
Hypothermic ardioplegic arrest (St. Thomas' Hospital solution, 4~ lasted for 3h at 10~ 
Adenosine triphosphate in treated hearts was significantly lower at the end of ischemia; 36+6% 
compared to 53 + 9 % for untreated hearts. 
Adenosine triphosphate inuntreated hearts recovered to 76 + 9 % after normothermic ischemia nd 
to 72 + 7% after hypothermic schemia t the end of 30 min repcrfusion. Captopril significantly 
improved adenosine triphosphatc recovery in both treated groups; 89 _+ 4 % after normothermic and 
83 _+ 4 % hypothermic ischemia. 
We conclude that captopril has a beneficial effect on recovery of adenosine triphosphate both after 
normothermic and after hypothermic ischemia. 
Key words: _captopril in ischemia; _captopril in cardioplegia; denosine triphosphate; 31-phosphorus 
nuclear magnetic resonance 
Introduction 
Reducing ischemic damage by the addition of drugs to coronary infusates i .an important 
way of obtaining effective myocardial protection under ischemic onditions. 
A number of drugs can be employed for their specific effects against ischemia-induced 
metabolic hanges (11) or against reperfusion-induced damage (5, 12). 
For many drugs investigated for their cardioprotective properties, however, it'is not clear 
which metabolic processes are particularly influenced. Captopril, an angiotensin-converting 
enzyme inhibitor, has been shown to reduce purine overflow upon reperfusion of ischemic 
hearts (3), suggesting that high energy phosphates in treated hearts were maintained at 
higher levels. 
Whether or not this was indeed due to the maintenance of higher ATP levels during 
ischemia or whether eperfusion-induced damage and subsequent purine loss was coun- 
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teracted could not be concluded from those findings. Therefore this study was undertaken to 
monitor the metabolism of adenosine triphosphate (ATP) during ischemia and subsequent 
repeffusion with 31-phosphorus-nuclear magnetic resonance (31P-NMR). 
In addition, the effects of temperature were studied, since some agents, e.g. calcium 
antagonists, are effective during normothermia (6) and not during hypothermia (14, 19). 
Therefore, in order to establish whether captopril maintains its beneficial effect during 
hypothermia we also compared normothermic and hypothermic onditions. 
Materials and Methods 
Perfusion model 
Male Wistar rats (220-260 g) were anesthetized with ether and given 500 IU of heparin intravenously. 
After rapid excision, the hearts were cooled in ice-cold saline. The aorta was cannulated and retrograde 
perfusion according to Langcndorff was started. Hearts were then allowed to beat spontaneously. The 
perfusion fluid was a modified Krebs-Henseleit buffer containing, in mM: NaCI 128.2; KCI 4.7; CaCI2 
1.3; MgCI2 1.1; NaHCO 3 20; glucose 10. In accordance with other investigators, no inorganic phosphate 
was added (9, 10, 13, 18). The perfusion fluid was equilibrated with 95 % O z and 5 % CO2 in a reservoir 
at 40 ~ warranting an oxygenated coronary perfusion at 37 ~ The perfusion pressure was hydrostati- 
cally maintained at 80 cm H20. The hearts were placed in a 15-mm diameter NMR-tube, while the 
perfusion tubing within the NMR-tube was centralized and supported by teflon discs. The hearts were 
immersed in the perfusate and excess perfusate was continuously aspirated using a vacuum suction 
pump. Global ischemia was accomplished by interrupting flow (study A). In study B, hearts were 
arrested with the St. Thomas' Hospital cardioplegic solution (8), which contained, in raM: NaCI 110; 
KCI 16; MgC12 16; CaC12 1.2; NaHCO3 10. 
The pH of the St. Thomas' Hospital solution was adjusted to 7.8 by titration with hydrochloric acid. 
The solution was then equilibratcd with 100 % 02 in a reservoir on melting ice for pcrfusion at a 
hydrostatic pressure of 80 cm H20. 
NMR methods 
Measurements were performed in a Bruker narrow bore 360 MHz magnet using a 15-mm home built 
31P probe. Spectra were collected using 60 ~ pulses and a relaxation delay of 2s. A frequency lock was 
not required. Signal-to-noise enhancement was accomplished using a negative xponential equivalent to 
a resonance line broadening of 30 Hz. Peak areas were measured by line fitting of all peaks. 
A change in temperature during the experiments in study B appeared to influence the tuning 
characteristics of the probe resulting in a higher signal-to-noise ratio at lower temperatures. It was 
therefore impossible to relate the intensities of spectra obtained at different emperatures during the 
experiment. The chemical shift of inorganic phosphate (P~) relative to the resonance frequency of 
creatine phosphate (CP) was used to calculate intracellular pH by means of the following equation (1): 
6o-c5b 
pHi = pK- log ~ ;  60 represents the difference in measured resonance position of Pi and CP in 
parts per million (ppm) at a given pH. The constants used in thc cquation are pK = 6.90, 6~ = 3.290 ppm 
and 6b = 5.805 ppm. 
Experimental design 
Study A 
12 hearts were studied. Six served as controls and six were treated with captopril 
(80 mg. 1 1). After 20 min of equilibration the perfusion was stopped for 15 rain. Subsequent 
reperfusion lasted for 30 rain. During the entire experiment, the temperature of probe and 
perfusate was maintained at 37~ Captopril treatment was started immediately after 
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Table 1. Effect of captopril on accumulation of inorganic phosphate during normothermic (A) and 
hypothermic (B) ischemia. Values are obtained from NMR spectra nd expressed in cm 2. 
A 0-5 rain 5-10 min 10-15 min 
Saline 2.2 _+ 0.5 2.8 _+ 0.7 3.6 + 0.6 
Captopril 1.6 + 0.1 2.2 + 0.2 2.5 + 0.2* 
B 0.5 h 1.0 h 2.0 h 3.0 h 
Saline 1.4 _+ 0.l 2.0 _+ 0.2 2.7 _+ 0.3 3.0 _+ 0.4 
Captopril 1.2 + 0.1 1.8 + 0.2 2.3 _+ 0.3 2.9 _+ 0.7 
* Significant difference when compared with untreated hearts (p < 0.05) 
cannulation of the aorta and was continued uring reperfusion. During the last 10 rain of the 
preischemic period, a control 31P-NMR spectrum (300 transients) was obtained. After the 
onset of ischemia, six 75 transient spectra (2.5 min) were obtained in immediate succession. 
Intracellular pH was calculated from 75 transient spectra. Intensities of the phosphorus 
metabolites were measured from 150 transient spectra obtained by addition of two 75 
transient spectra, accumulated between 0-5 min, 5-10 min and 10-15 min, respectively. 
During reperfusion, two 300 transient spectra were obtained between 5-15 rain and 20-30 
min, respectively. Values of CP and ATP during ischemia nd reperfusion were expressed as 
percentages of their preischemic values. No reliable control values of P~ could be obtained, 
because of very low Pi intensities prior to ischemia. Its accumulation during ischemia is 
expressed as the mean of integrated intensities for treated and untreated groups (Table 1). 
Examples of 300 and 150 transient spectra obtained uring normothermic perfusion and 
ischemia re shown in Fig. 1. 
Study 13 
12 hearts were studied of which six were treated with captopril (80 rag. 1-1). After 30 min 
equilibration, cardioplegic arrest was accomplished during a 4-min perfusion with the St. 
Thomas' Hospital solution. The temperature of this cardioplegic infusate was 4 ~ during 
administration the probe was cooled to 10 ~ The probe temperature was thermostatically 
maintained at 10 ~ during 3 h of ischemia. Upon reperfusion, the temperature was raised 
again to 37 ~ Captopril treatment was started at the onset of perfusion and was continued 
throughout he experiment. Captopril (80 mg.1 -~) was also added to the cardioplegic 
solution. A 300 transient spectrum (10 rain) was obtained prior to cardioplegic arrest, 
serving as a control for reperfusion measurements. Another 300 transient spectrum was 
obtained immediately after cardioplegic perfusion and served as control for six subsequent 
300 transient spectra obtained at 30-rain intervals during ischemia. During subsequent 
reperfusion (30 min) two spectra were obtained between 5-15 rain and 20-30 min. Accumu- 
lation of Pi during ischemia was expressed as the mean of integrated intensities for the 
treated and untreated groups. 
Statistical procedures 
Results hown in the tables and graphs are means _+ SEM. The means were compared by 
using the Student's t-test and p = 0.05 was taken as the limit of significance. 
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Fig. 1. Spectra obtained in study A; normothermic ischemia. AI: equilibration (300 transients); A2: 
10-15 rain of ischemia (150 transients); A3: reperfusion (300 transients). 
Resu l ts  
Study A 
Equilibration: Absolute intensities of ATP and CP in captopril-treated hearts were not 
different from those in untreated hearts when the means were compared. A reliable stimate 
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Fig. 2. Changes in ATP and CP for treated and untreated hearts during normothermic ischemic arrest 
and subsequent reperfusion are plotted against time. 
* Significant difference when compared with untreated hearts (p < 0.05) 
of the intracellular pH could not be obtained uring equilibration since no Pi could be 
detected. 
Normothermic ischemia: CP disappeared after 10 rain of ischemia in both untreated and 
captopril-treated hearts. However, CP in captopril-treated hearts decreased significantly 
slower during the first 5 min (to 53 + 12 % and 30 + 8 %, respectively; Fig. 2). ATP in 
untreated hearts decreased to 53 + 9 % of initial values at the end of ischemia. In captopril- 
treated hearts, ATP decreased more slowly initially, but end-ischemic levels were compa- 
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Fig. 3. Decrease of pH during normothermic ischemic arrest for treated and untreated hearts. 
* Significantly ower pH when compared with untreated hearts (p < 0.05) 
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Fig. 4. Changes in ATP and CP for treated and untreated hearts during hypothermic cardioplegic arrest 
and subsequent.reperfusion are plotted against ime. 
* Significant difference when compared with untreated hearts (p <: 0.05) 
5 min; 89-+ 5 % compared to 76-4-9 % for untreated hearts (Fig. 2). Intracellular pH in 
captopril-treated hearts was already significantly lower at the onset of ischemia and 
decreased at the same rate as untreated hearts to a significantly lower end-ischemic level, 
6.01-+0.07 and 6.24-+0.11 for untreated hearts (Fig. 3). Accumulation of inorganic 
phosphate was clearly less in treated hearts during the entire period of ischemia and 
significantly lower at the end of ischemia (Table 1A). 
Reperfusion: ATP in untreated hearts returned to 75 + 11% of preischemic values after 
5 min of reperfusion, followed by a slight fall to 72 + 7 % at the end of reperfusion. CP 
recovered completely and remained constant during the entire reperfusion period (Fig. 2). 
ATP recovered to higher levels in treated hearts than in untreated hearts, which was 
significant after 20 min, 83-+ 4 % versus 72 + 7 %. CP in treated hearts recovered above 
initial values during the entire reperfusion period (Fig. 2), but no significant differences 
were observed when compared to untreated hearts. Inorganic phosphate was not detectable 
upon reperfusion, and thus no intracellular pH could be obtained. 
Study B 
Equilibration and cardioplegic perfusion: No inorganic phosphate was detected and there- 
fore intracellular pH could not be estimated uring normothermic equilibration. Changes in 
the levels of the phosphorus metabolites due to oxygenated cardioplegic perfusion after 
equilibration could not be assessed, because of the changes in probe tuning characteristics, 
as mentioned in the Methods section. However, peak height ratios of all peaks measured 
immediately after arrest were similar to those during equilibration. 
The intracellular pH was above physiological levels as a consequence of the alkaline 
cardioplegic solution (7.8). The pH was 7.58-+ 0.03 for treated hearts and 7.56-+ 0.1 for 
controls. 
Hypothermic ischemia: Figure 4 shows that ATP decreased steadily and linearly in un- 
treated hearts; after 3 h 53 + 9 % remained. CP decreased relatively fast within the first hour 
to 27 _+ 8 % and had almost disappeared after 2 h. Intracellular pH (Fig. 5) dropped linearly 
during the first 189 (0.92 units) continuing to decline less rapidly during the second half of 
the ischemic period (0.48 units) and resulting in an end-ischemic pH of 6.16 + 0.04. The 
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Fig. 5. Time course of tissue pH during hypothermic cardioplegic arrest after an initial peffusion for 
4 min (arrow on abscissa). 
* p < 0.05 when compared with untreated hearts. 
decrease of ATP in captopril-treated hearts was similar to that in untreated hearts during the 
initial phase of ischemia, 72 _+ 4 % compared to 69 _+ 5 % for untreated hearts after 2 h. 
Thereafter, a further decrease in ATP in treated hearts resulted in a significantly lower end- 
ischemic ATP; 36 + 6 % compared to 53 _+ 9 % for untreated hearts (Fig. 4). Intracellular 
pH in captopril-treated hearts decreased similarly as in untreated hearts (0.90 units) during 
the first 189 Thereafter captopril-treated hearts howed a more gradual decline in pH (0.29 
units) resulting in a significantly higher end-ischemic pH 6.39_+0.07 compared to 
6.16 _+ 0.04 for untreated hearts (Fig. 5). 
Table 1B shows that the accumulation of inorganic phosphate was similar in both groups. 
Reperfusion: ATP in untreated hearts recovered to 73 + 7 % of preischemic values initially 
but showed a subsequent decrease to 67 _+ 7 % at the end of reperfusion. The initial recovery 
of ATP to 77 _+ 3 % in treated hearts was similar to untreated hearts, but in contrast o the 
subsequent decrease in untreated hearts, ATP in all treated hearts recovered even more at 
the end of the reperfusion period, resulting in a significantly higher ATP; 83 _+ 3 % versus 
67+7%.  
CP, in both groups, recovered to above the initial level and was stable during the entire 
period showing no (significant) differences between treated and untreated hearts (Fig. 4). 
Inorganic phosphate was not detectable during reperfusion and therefore intracellular pH 
could not be obtained for either group. 
Discussion 
NMR spectroscopy has the advantages of monitoring ATP metabolism continuously while 
tissue integrity is maintained. However, it is difficult to calibrate signals obtained from 
intramyocardial phosphorus metabolites with absolute tissue concentrations, as it is 
necessary to calibrate for each heart individually. But it has been shown that changes in peak 
intensities correlate linearly with tissue concentrations (10). 
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In this study, we have shown that captopril improves the recovery of ATP during 
reperfusion, both after normothermic and after hypothermic ischemia. 
During normothermic ischemia, ATP and CP levels decreased at a slower rate and 
accumulation of inorganic phosphate was significantly reduced compared to untreated 
hearts. This suggests that, at the end of normothermic ischemia, the degree of dephosphory- 
lation in treated hearts was reduced and that more nucleotides were readily available for 
rephosphorylation to ATP upon reperfusion. However, the difference in levels of inorganic 
phosphate in both groups could also be due to a different membrane phospholipid metabo- 
lism or a difference in precipitation with free calcium, which is elevated uring ischemia 
(11). 
During hypothermic schemia, captopril did not reduce the rate of ATP catabolism. ATP 
levels were actually even lower at the end of the hypothermic period when compared to 
untreated hearts. However, captopril treated hearts showed an improved maintenance of 
intraeellular pH during this period. Apparently this pH effect is not the result of reduced 
hydrolysis of ATP (9, 18). A possible explanation for this phenomenon could be an 
inhibition of glycolytic flux, which would lead to a slower decrease of intracellular pH and an 
increased rate of ATP depletion (2). 
Another observation is the lack of a relationship between end-ischemic ATP levels and 
the recovery at ATP during reperfusion under both conditions. Therefore, we conclude that 
prior to reperfusion ATP levels as such are poor markers for myocardial recovery, which 
was also found by others (13, 17). The amount of precursors available for rephosphorylation 
probably correlates much better with recovery of ATP levels. This underlines the 
importance of monitoring the loss of purines during ischemia and reperfusion (17). 
The more efficient restoration of ATP in treated hearts could be due to an effect of 
captopril in the reperfusion phase. This could be due to a better preservation of ATP- 
generating enzyme systems (12, 15) or by counteraction of reperfusion-induced tissue injury 
(5, 12). 
The ATP and CP levels were much better maintained uring hypothermic cardiac arrest 
than during normothermia. For instance, a drop in ATP levels to approximately 50% 
occurred after 15 rain normothermia, whereas this reduction took 180 rain during hypother- 
mic cardioplegia. Interestingly, captopril improved recovery of the heart, as measured by 
ATP and CP levels, under this condition of improved ischemic tolerance. Its effects on 
ischemie metabolism, however, appeared to be different under both conditions. During 
normothermic ischemia, effects of captopril are apparent during the initial phase of 
ischemia, whereas during hypothermic schemia, effects appear in a later phase. The latter 
could be due to hypothermia and the use of the St. Thomas' Hospital solution, which make it 
difficult for any drug to superimpose an additional effect, especially during the initial phase. 
During normothermic schemia, however, it is conceivable that any protective ffect will 
already be observed early in ischemia. This is also seen with Ca entry blockers; besides their 
attributed effects during normothermic ischemia, it has been proposed that they also exert a 
cardioplegic effect by lowering oxygen demand and contractility (16). With captopril, such 
an effect seems unlikely, because previous studies have shown that captopril does not 
influence pressure rate index (3). 
The effect of captopril might be due to another mechanism which is temperature 
dependent. Previous studies have shown that captopril influences the catecholamine over- 
flow due to ischemia and reperfusion (4). It is conceivable that the effect of a reduced 
catecholamine overflow will be more pronounced under normothermic conditions than 
during hypothermia (Study B). During normothermic reperfusion, overflow of catechol- 
amines will impair recovery. Therefore, captopril might be effective, especially during this 
phase, which is in accordance with our own findings. This mechanism ust be considered 
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speculative until catecholamine efflux data from hypothermic cardiac arrest experiments are 
available. 
In conclusion, the observed effects indicate that captopril may be beneficial as an additive 
to cardioplegic solutions and during normothermic ischemia followed by reperfusion. The 
latter effect makes captopril potentially useful as comedication during thrombolytic pro- 
cedures, which are increasingly performed clinically. However,  for a rational use of 
captopril in these settings, further elucidation of the underlying mechanism is needed. 
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